KAZOparin-40
Description_Effects
KAZOparin-40 contains Enoxaparin Sodium 40 mg, a low molecular weight heparin (LMWH) used as an anticoagulant (blood thinner). It is primarily prescribed to prevent the formation of harmful blood clots in individuals who are at increased risk due to prolonged bed rest, major surgeries like hip or knee replacement, or abdominal surgeries. Patients in these conditions are more prone to developing deep vein thrombosis (DVT) — a condition in which blood clots form in the deep veins, usually in the legs. If untreated, these clots can travel to the lungs and cause a pulmonary embolism, which can be life-threatening. KAZOparin-40 works by inhibiting clotting factors, especially Factor Xa, to prevent the formation and growth of blood clots. It is given by subcutaneous injection, usually once a day under medical supervision. This medication plays a critical role in postoperative care and immobilized patients, reducing the risk of clot-related complications. While on this medication, it is important to monitor for signs of bleeding, bruising, or allergic reactions, and inform the doctor about any other medications being taken to avoid interactions. With proper use, KAZOparin-40 helps ensure safe recovery and reduces the risk of serious clotting events.
